Artificial liver support system in treatment of liver failure after acute poisoning
- PMID: 25215024
- PMCID: PMC4129729
- DOI: 10.5847/wjem.j.1920-8642.2011.04.007
Artificial liver support system in treatment of liver failure after acute poisoning
Abstract
Background: Acute poisoning (AP) may cause failure of the liver and kidney, and even death. This study aimed to investigate the efficacy of artificial liver support system (ALSS) on the treatment of liver failure after acute poisoning.
Methods: A total of 31 patients with liver failure caused by AP were admitted to emergency ICU, central ICU, and Department of Gastroenterology from 2005 to 2009 in Zhongshan Hospital Affiliated to Xiamen University, China. Among them, 13 patients served as a treatment group, and used ALSS in addition to detoxification treatment and protective treatment of liver function, and the other 18 patients served as a control group receiving detoxification treatment and protective treatment of liver function.
Results: In the treatment group, 10 patients (76.9%) were cured or improved, 2 died, and 1 was discharged against advice. In the 18 patients in the control group, 7 (38.9%) were cured or improved, 3 died, and 8 were discharged against advice. There was a significant difference in the rates of improvement between the two groups (P<0.05).
Conclusion: ALSS is a safe and effective clinical method for the treatment of acute toxic liver failure.
Keywords: Artificial liver support system; Liver failure; Toxicity.
Similar articles
-
[Predictive value of pediatrics end-stage liver disease or model for end-stage liver disease score in the prognosis of pediatric acute liver failure treated with artificial liver support system].Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):280-4. Zhonghua Er Ke Za Zhi. 2015. PMID: 26182503 Chinese.
-
Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system.PLoS One. 2017 Apr 20;12(4):e0175332. doi: 10.1371/journal.pone.0175332. eCollection 2017. PLoS One. 2017. PMID: 28426800 Free PMC article.
-
[Survival analysis on liver failure patients treated with an artificial liver support system].Zhonghua Gan Zang Bing Za Zhi. 2006 Sep;14(9):647-51. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16995975 Clinical Trial. Chinese.
-
Artificial liver support system in China: a review over the last 30 years.Ther Apher Dial. 2006 Apr;10(2):160-7. doi: 10.1111/j.1744-9987.2006.00358.x. Ther Apher Dial. 2006. PMID: 16684218 Review.
-
Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.Clin Toxicol (Phila). 2011 Nov;49(9):782-93. doi: 10.3109/15563650.2011.624102. Clin Toxicol (Phila). 2011. PMID: 22077243 Review.
Cited by
-
N,N-dimethylformamide-induced acute hepatic failure: A case report and literature review.Exp Ther Med. 2017 Dec;14(6):5659-5663. doi: 10.3892/etm.2017.5213. Epub 2017 Sep 27. Exp Ther Med. 2017. PMID: 29285107 Free PMC article.
References
-
- Li B, Xin S, Xing H, Zhao J, Zou Z, Zhang B, et al. Treatment of severe viral hepatitis with artificial liver support system. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002;16:157–159. - PubMed
-
- Qian Y, Lanjuan L, Jianrong H, Jun L, Hongcui C, Suzhen F, et al. Study of severe hepatitis treated with a hybrid artificial liver support system. Int J Artif Organs. 2003;26:507–513. - PubMed
-
- Zhu YG, Zhang YY, Lu H, Gao JH, Gu JL. A clinical study of severe hepatitis treated with a partial plasma exchange artificial liver support system. Zhonghua Gan Zang Bing Za Zhi. 2006;14:616–617. - PubMed
-
- Aggarwal P, Handa R, Wali JP. Acute Poisoning-Management Guidelines. J Indian Acad Clin Med. 2004;5:142–147.
LinkOut - more resources
Full Text Sources